대한간학회지 (Clinical and Molecular Hepatology)

  • 제24권4호
  • /
  • Pages.358-366
  • /
  • 2018
  • /
  • 2287-2728(pISSN)
  • /
  • 2287-285X(eISSN)
대한간학회 (The Korean Association for the Study of the Liver)
권호 표지
DOI QR코드

DOI QR Code

Severe acute alcoholic hepatitis and liver transplant: A never-ending mournful story

  • Obed, Aiman (Division of General, Hepatobiliary and Transplant Surgery, Jordan Hospital) ;
  • Bashir, Abdalla (Division of General, Hepatobiliary and Transplant Surgery, Jordan Hospital) ;
  • Stern, Steffen (Faculty of Law, Bielefeld University) ;
  • Jarrad, Anwar (Division of Gastroenterology, Jordan Hospital)
  • 투고 : 2018.05.26
  • 심사 : 2018.08.16
  • 발행 : 2018.12.25
⟨ 이전 논문 다음 논문 ⟩

초록

Severe acute alcoholic liver disease (SAAH) unresponsive to medical therapy shows one-year-mortality rates of up to 90%. Most transplant centers request six months of alcohol abstinence prior to transplantation, the so-called "6-month rule." This regulation is not based on strong evidence, repeatedly making it a topic of controversial debates. The majority of patients with SAAH will die before fulfilling the 6-month rule. Therefore, liver transplantation (LT) protocols are becoming more flexible towards the rigid abstinence regulation, especially concerning SAAH patients. We conducted a literature review regarding LT in SAAH and its outcomes, including post-transplant mortality and recidivism. We studied available data on PubMed from 2011 and onwards whilst including articles dealing with genetic components, medical therapy and historic snapshots of alcoholism. Emerging studies recommend LT in SAAH not responding to medical therapies even without realizing the required abstinence period, since the majority of these patients would die within 6 months. SAAH without response to medical therapy has one-year-mortality rates of up to 90%. The 6-month rule is not based on strong evidence and is repeatedly a topic of controversial debates. There is genetic linkage to alcoholism and medical therapy is not as effective as estimated, yet. The 6-months-regulation has not shown to evidently decrease the risk of recidivism post-LT, which is a lifesaving treatment in SAAH patients. Insisting on rigid sobriety rules results in excluding patients with a low risk of recidivism from being transplanted. Moreover, the genetic linkage of alcoholism must be recognized.

키워드

참고문헌

  1. Testino G. Alcoholic diseases in hepato-gastroenterology: a point of view. Hepatogastroenterology 2008;55:371-377.
  2. Crawford JM. Vascular disorders of the liver. Clin Liver Dis 2010;14:635-650. https://doi.org/10.1016/j.cld.2010.08.002
  3. European Association for the Study of Liver. EASL clinical practice guidelines: management of alcoholic liver disease. J Hepatol 2012;57:399-420. https://doi.org/10.1016/j.jhep.2012.04.004
  4. Sohail U, Satapathy SK. Diagnosis and management of alcoholic hepatitis. Clin Liver Dis 2012;16:717-736. https://doi.org/10.1016/j.cld.2012.08.005
  5. Mathurin P, Moreno C, Samuel D, Dumortier J, Salleron J, Durand F, et al. Early liver transplantation for severe alcoholic hepatitis. N Engl J Med 2011;365:1790-1800. https://doi.org/10.1056/NEJMoa1105703
  6. Hoofnagle JH, Kresina T, Fuller RK, Lake JR, Lucey MR, Sorrell MF, et al. Liver transplantation for alcoholic liver disease: executive statement and recommendations. Summary of a National Institutes of Health workshop held December 6-7, 1996, Bethesda, Maryland. Liver Transpl Surg 1997;3:347-350. https://doi.org/10.1002/lt.500030324
  7. Tandon P, Goodman KJ, Ma MM, Wong WW, Mason AL, Meeberg G, et al. A shorter duration of pre-transplant abstinence predicts problem drinking after liver transplantation. Am J Gastroenterol 2009;104:1700-1706. https://doi.org/10.1038/ajg.2009.226
  8. Leong J, Im GY. Evaluation and selection of the patient with alcoholic liver disease for liver transplant. Clin Liver Dis 2012;16:851-863. https://doi.org/10.1016/j.cld.2012.08.012
  9. Miguet M, Monnet E, Vanlemmens C, Gache P, Messner M, Hruskovsky S, et al. Predictive factors of alcohol relapse after orthotopic liver transplantation for alcoholic liver disease. Gastroenterol Clin Biol 2004;28(10 Pt 1):845-851. https://doi.org/10.1016/S0399-8320(04)95146-9
  10. Donckier V, Lucidi V, Gustot T, Moreno C. Ethical considerations regarding early liver transplantation in patients with severe alcoholic hepatitis not responding to medical therapy. J Hepatol 2014;60:866-871. https://doi.org/10.1016/j.jhep.2013.11.015
  11. Neuberger J, Adams D, MacMaster P, Maidment A, Speed M. Assessing priorities for allocation of donor liver grafts: survey of public and clinicians. BMJ 1998;317:172-175. https://doi.org/10.1136/bmj.317.7152.172
  12. Stroh G, Rosell T, Dong F, Forster J. Early liver transplantation for patients with acute alcoholic hepatitis: public views and the effects on organ donation. Am J Transplant 2015;15:1598-1604. https://doi.org/10.1111/ajt.13176
  13. O'Shea RS, Dasarathy S, McCullough AJ. Alcoholic liver disease. Am J Gastroenterol 2010;105:14-32; quiz 33. https://doi.org/10.1038/ajg.2009.593
  14. O'Shea RS, Dasarathy S, McCullough AJ; Practice Guideline Committee of the American Association for the Study of Liver Diseases; Practice Parameters Committee of the American College of Gastroenterology. Alcoholic liver disease. Hepatology 2010;51:307-328. https://doi.org/10.1002/hep.23258
  15. Maddrey WC, Boitnott JK, Bedine MS, Weber FL Jr, Mezey E, White RI Jr. Corticosteroid therapy of alcoholic hepatitis. Gastroenterology 1978;75:193-199. https://doi.org/10.1016/0016-5085(78)90401-8
  16. Thursz MR, Richardson P, Allison M, Austin A, Bowers M, Day CP, et al. Prednisolone or pentoxifylline for alcoholic hepatitis. N Engl J Med 2015;372:1619-1628. https://doi.org/10.1056/NEJMoa1412278
  17. Louvet A, Naveau S, Abdelnour M, Ramond MJ, Diaz E, Fartoux L, et al. The Lille model: a new tool for therapeutic strategy in patients with severe alcoholic hepatitis treated with steroids. Hepatology 2007;45:1348-1354. https://doi.org/10.1002/hep.21607
  18. Louvet A, Diaz E, Dharancy S, Coevoet H, Texier F, Thevenot T, et al. Early switch to pentoxifylline in patients with severe alcoholic hepatitis is inefficient in non-responders to corticosteroids. J Hepatol 2008;48:465-470. https://doi.org/10.1016/j.jhep.2007.10.010
  19. Strieter RM, Remick DG, Ward PA, Spengler RN, Lynch JP 3rd, Larrick J, et al. Cellular and molecular regulation of tumor necrosis factoralpha production by pentoxifylline. Biochem Biophys Res Commun 1988;155:1230-1236. https://doi.org/10.1016/S0006-291X(88)81271-3
  20. Akriviadis E, Botla R, Briggs W, Han S, Reynolds T, Shakil O. Pentoxifylline improves short-term survival in severe acute alcoholic hepatitis: a double-blind, placebo-controlled trial. Gastroenterology 2000;119:1637-1648. https://doi.org/10.1053/gast.2000.20189
  21. Park SH, Kim DJ, Kim YS, Yim HJ, Tak WY, Lee HJ, et al. Pentoxifylline vs. corticosteroid to treat severe alcoholic hepatitis: a randomised, non-inferiority, open trial. J Hepatol 2014;61:792-798. https://doi.org/10.1016/j.jhep.2014.05.014
  22. Nguyen-Khac E, Thevenot T, Piquet MA, Benferhat S, Goria O, Chatelain D, et al. Glucocorticoids plus N-acetylcysteine in severe alcoholic hepatitis. N Engl J Med 2011;365:1781-1789. https://doi.org/10.1056/NEJMoa1101214
  23. Lewy J. A sober Reich? Alcohol and tobacco use in Nazi Germany. Subst Use Misuse 2006;41:1179-1195. https://doi.org/10.1080/10826080500514479
  24. Gotz A, Peter C, Pross C. Cleansing the Fatherland: Contributions to National Socialist Health and Social Policy. 1st ed. Baltimore and London: Johns Hopkins University Press, 1994;978:0-8018-4775-2.
  25. Welch CS. Liver graft. Maroc Med 1955;34:514-515.
  26. Moore FD, Smith LL, Burnap TK, Dallenbach FD, Dammin GJ, Gruber UF, et al. One-stage homotransplantation of the liver following total hepatectomy in dogs. Transplant Bull 1959;6:103-107.
  27. Starzl TE, Marchioro TL, Vonkaulla KN, Hermann G, Brittain RS, Waddell WR. Homotransplantation of the liver in humans. Surg Gynecol Obstet 1963;117:659-676.
  28. Starzl TE, Putnam CW, Ishikawa M, Picache R, Husberg B, Halgrimson CG, et al. Current policies in hepatic transplantation: candidacy of patients with alcoholic liver disease or preformed antidonor antibodies and a reappraisal of biliary duct reconstruction. Ann N Y Acad Sci 1975;252:145-158. https://doi.org/10.1111/j.1749-6632.1975.tb19151.x
  29. Iwatsuki S, Starzl TE, Todo S, Gordon RD, Tzakis AG, Marsh JW, et al. Liver transplantation in the treatment of bleeding esophageal varices. Surgery 1988;104:697-705.
  30. Tawa EA, Hall SD, Lohoff FW. Overview of the genetics of alcohol use disorder. Alcohol Alcohol 2016;51:507-514. https://doi.org/10.1093/alcalc/agw046
  31. Heath AC, Bucholz KK, Madden PA, Dinwiddie SH, Slutske WS, Bierut LJ, et al. Genetic and environmental contributions to alcohol dependence risk in a national twin sample: consistency of findings in women and men. Psychol Med 1997;27:1381-1396. https://doi.org/10.1017/S0033291797005643
  32. Agrawal A, Lynskey MT. Are there genetic influences on addiction: evidence from family, adoption and twin studies. Addiction 2008;103:1069-1081. https://doi.org/10.1111/j.1360-0443.2008.02213.x
  33. Enoch MA. The role of early life stress as a predictor for alcohol and drug dependence. Psychopharmacology (Berl) 2011;214:17-31. https://doi.org/10.1007/s00213-010-1916-6
  34. Frank J, Cichon S, Treutlein J, Ridinger M, Mattheisen M, Hoffmann P, et al. Genome-wide significant association between alcohol dependence and a variant in the ADH gene cluster. Addict Biol 2012;17:171-180. https://doi.org/10.1111/j.1369-1600.2011.00395.x
  35. Torruellas C, French SW, Medici V. Diagnosis of alcoholic liver disease. World J Gastroenterol 2014;20:11684-11699. https://doi.org/10.3748/wjg.v20.i33.11684
  36. Bird GL, O'Grady JG, Harvey FA, Calne RY, Williams R. Liver transplantation in patients with alcoholic cirrhosis: selection criteria and rates of survival and relapse. BMJ 1990;301:15-17. https://doi.org/10.1136/bmj.301.6742.15
  37. Kumar S, Stauber RE, Gavaler JS, Basista MH, Dindzans VJ, Schade RR, et al. Orthotopic liver transplantation for alcoholic liver disease. Hepatology 1990;11:159-164.
  38. Osorio RW, Ascher NL, Avery M, Bacchetti P, Roberts JP, LakeJR. Predicting recidivism after orthotopic liver transplantation for alcoholic liver disease. Hepatology 1994;20(1 Pt 1):105-110.
  39. Obed A, Stern S, Jarrad A, Lorf T. Six month abstinence rule for liver transplantation in severe alcoholic liver disease patients. World J Gastroenterol 2015;21:4423-4426. https://doi.org/10.3748/wjg.v21.i14.4423
  40. Cohen C, Benjamin M. Alcoholics and liver transplantation. The Ethics and Social Impact Committee of the Transplant and Health Policy Center. JAMA 1991;265:1299-1301. https://doi.org/10.1001/jama.1991.03460100101033
  41. Caplan AL, Coelho DH. The ethics of organ transplants: the current debate. New York: Prometheus Books, 1998.
  42. Glannon W. Responsibility, alcoholism, and liver transplantation. J Med Philos 1998;23:31-49. https://doi.org/10.1076/jmep.23.1.31.2595
  43. Lucey MR, Merion RM, Henley KS, Campbell DA Jr, Turcotte JG, Nostrant TT, et al. Selection for and outcome of liver transplantation in alcoholic liver disease. Gastroenterology 1992;102:1736-1741. https://doi.org/10.1016/0016-5085(92)91737-O
  44. Soterakis J, Resnick R, Iber F. Effects of alcohol abstinence on survival in cirrhotic portal hypertension: report from the Boston Inter-Hospital Liver Group. Lancet 1973;302:65-67. https://doi.org/10.1016/S0140-6736(73)93261-3
  45. Pande NV, Resnick RH, Yee W, Eckardt VP, Shurberg JL. Cirrhotic portal hypertension: morbidity of continued alcoholism. Gastroenterology 1978;74:64-69. https://doi.org/10.1016/0016-5085(78)90357-8
  46. Dixon J, Welch HG. Priority setting: lessons from Oregon. Lancet 1991;337:891-894. https://doi.org/10.1016/0140-6736(91)90213-9
  47. Chan HM, Cheung GM, Yip AK. Selection criteria for recipients of scarce donor livers: a public opinion survey in Hong Kong. Hong Kong Med J 2006;12:40-46.
  48. Neuberger J. Public and professional attitudes to transplanting alcoholic patients. Liver Transpl 2007;13(11 Suppl 2):S65-S68. https://doi.org/10.1002/lt.21337
  49. Brown RS Jr. Transplantation for alcoholic hepatitis--time to rethink the 6-month “rule”. N Engl J Med 2011;365:1836-1838. https://doi.org/10.1056/NEJMe1110864
  50. Addolorato G, Mirijello A, Leggio L, Ferrulli A, D'Angelo C, Vassallo G, et al. Liver transplantation in alcoholic patients: impact of an alcohol addiction unit within a liver transplant center. Alcohol Clin Exp Res 2013;37:1601-1608. https://doi.org/10.1111/acer.12117
  51. Singal AK, Kamath PS, Gores GJ, Shah VH. Alcoholic hepatitis: current challenges and future directions. Clin Gastroenterol Hepatol 2014;12:555-564. https://doi.org/10.1016/j.cgh.2013.06.013
  52. Testino G, Borro P, Ancarani O, Sumberaz A. Human carcinogenesis and alcohol in hepato-gastroenterology. Eur Rev Med Pharmacol Sci 2012;16:512-518.
  53. Rice JP, Lucey MR. Should length of sobriety be a major determinant in liver transplant selection? Curr Opin Organ Transplant 2013;18:259-264. https://doi.org/10.1097/MOT.0b013e32835fb94b
  54. Testino G, Burra P, Bonino F, Piani F, Sumberaz A, Peressutti R, et al. Acute alcoholic hepatitis, end stage alcoholic liver disease and liver transplantation: an Italian position statement. World J Gastroenterol 2014;20:14642-14651. https://doi.org/10.3748/wjg.v20.i40.14642
  55. Im GY, Kim-Schluger L, Shenoy A, Schubert E, Goel A, Friedman SL, et al. Early liver transplantation for severe alcoholic hepatitis in the United States--a single-center experience. Am J Transplant 2016;16:841-849. https://doi.org/10.1111/ajt.13586
  56. Addolorato G, Bataller R, Burra P, DiMartini A, Graziadei I, Lucey MR, et al. Liver transplantation for alcoholic liver disease. Transplantation 2016;100:981-987. https://doi.org/10.1097/TP.0000000000001156
  57. Testino G, Leone S. Acute alcoholic hepatitis: a literature review and proposal of treatment. Minerva Med 2018;109:290-299.
  58. Testino G, Scafato E, Patussi V. Acute alcoholic hepatitis. Recenti Prog Med 2017;108:366-373.
  59. Zhu J, Chen PY, Frankel M, Selby RR, Fong TL. Contemporary policies regarding alcohol and marijuana use among liver transplant programs in the United States. Transplantation 2018;102:433-439.
  60. Jesudian AB, Brown RS Jr. Acute alcoholic hepatitis as indication for liver transplantation. Curr Opin Organ Transplant 2016;21:107-110. https://doi.org/10.1097/MOT.0000000000000285
  61. Germani G, Zanetto A, Ferrarese A, Russo FP, Senzolo M, Burra P. Orthotopic liver transplantation in alcoholic liver disease patients. Rev Recent Clin Trials 2016;11:253-259. https://doi.org/10.2174/1574887111666160815102228
  62. Lee BP, Chen PH, Haugen C, Hernaez R, Gurakar A, Philosophe B, et al. Three-year results of a pilot program in early liver transplantation for severe alcoholic hepatitis. Ann Surg 2016;265:20-29.
  63. Daswani R, Kumar A, Sharma P, Singla V, Bansal N, Arora A. Role of liver transplantation in severe alcoholic hepatitis. Clin Mol Hepatol 2018;24:43-50. https://doi.org/10.3350/cmh.2017.0027
  64. Hong SK, Yi NJ, Kim HS, Ahn SW, Yoon KC, Kim H, et al. Korean patients undergoing deceased donor liver transplantation for alcoholic liver disease have non-inferior survival outcomes than for hepatitis B virus: a real-world experience without minimum abstinence before transplantation. J Korean Med Sci 2017;32:919-925. https://doi.org/10.3346/jkms.2017.32.6.919
  65. Gutmann T, Schneewind KA, Schroth U, Schmidt VH, Elsasser A, Land W, et al. Basics of a fair organ distribution: Medicine-Psychology-Law-Ethics-Sociology (MedR Series Medical Law). 8th ed. Berlin: Springer, 2003:9-78.
  66. Prince MI, Hudson M. Liver transplantation for chronic liver disease: advances and controversies in an era of organ shortages. Postgrad Med J 2002;78:135-141. https://doi.org/10.1136/pmj.78.917.135
  67. Pereira SP, Howard LM, Muiesan P, Rela M, Heaton N, Williams R. Quality of life after liver transplantation for alcoholic liver disease. Liver Transpl 2000;6:762-768. https://doi.org/10.1053/jlts.2000.19030
  68. Kranzler HR, Armeli S, Wetherill R, Feinn R, Tennen H, Gelernter J, et al. Self-efficacy mediates the effects of topiramate and GRIK1 genotype on drinking. Addict Biol 2016;21:450-459. https://doi.org/10.1111/adb.12207
  69. Ferraguti G, Pascale E, Lucarelli M. Alcohol addiction: a molecular biology perspective. Curr Med Chem 2015;22:670-684. https://doi.org/10.2174/0929867321666141229103158
  70. Dick DM, Edenberg HJ, Xuei X, Goate A, Kuperman S, Schuckit M, et al. Association of GABRG3 with alcohol dependence. Alcohol Clin Exp Res 2004;28:4-9. https://doi.org/10.1097/01.ALC.0000108645.54345.98
  71. Dick DM, Bierut L, Hinrichs A, Fox L, Bucholz KK, Kramer J, et al. The role of GABRA2 in risk for conduct disorder and alcohol and drug dependence across developmental stages. Behav Genet 2006;36:577-590. https://doi.org/10.1007/s10519-005-9041-8
  72. Dick DM, Plunkett J, Wetherill LF, Xuei X, Goate A, Hesselbrock V, et al. Association between GABRA1 and drinking behaviors in the collaborative study on the genetics of alcoholism sample. Alcohol Clin Exp Res 2006;30:1101-1110. https://doi.org/10.1111/j.1530-0277.2006.00136.x
  73. Dick DM, Agrawal A, Wang JC, Hinrichs A, Bertelsen S, Bucholz KK, et al. Alcohol dependence with comorbid drug dependence: genetic and phenotypic associations suggest a more severe form of the disorder with stronger genetic contribution to risk. Addiction 2007;102:1131-1139. https://doi.org/10.1111/j.1360-0443.2007.01871.x
  74. Dick DM, Wang JC, Plunkett J, Aliev F, Hinrichs A, Bertelsen S, et al. Family-based association analyses of alcohol dependence phenotypes across DRD2 and neighboring gene ANKK1. Alcohol Clin Exp Res 2007;31:1645-1653. https://doi.org/10.1111/j.1530-0277.2007.00470.x
  75. Jones KA, Porjesz B, Almasy L, Bierut L, Goate A, Wang JC, et al. Linkage and linkage disequilibrium of evoked EEG oscillations with CHRM2 receptor gene polymorphisms: implications for human brain dynamics and cognition. Int J Psychophysiol 2004;53:75-90. https://doi.org/10.1016/j.ijpsycho.2004.02.004
  76. Luo X, Kranzler HR, Zuo L, Lappalainen J, Yang BZ, Gelernter J. ADH4 gene variation is associated with alcohol dependence and drug dependence in European Americans: results from HWD tests and case-control association studies. Neuropsychopharmacology 2006;31:1085-1095. https://doi.org/10.1038/sj.npp.1300925
  77. Luo X, Kranzler HR, Zuo L, Wang S, Blumberg HP, Gelernter J. CHRM2 gene predisposes to alcohol dependence, drug dependence, and affective disorders: results from an extended case-control structured association study. Hum Mol Genet 2005;14:2421-2434. https://doi.org/10.1093/hmg/ddi244
  78. Wang JC, Hinrichs AL, Stock H, Budde J, Allen R, Bertelsen S, et al. Evidence of common and specific genetic effects: association of the muscarinic acetylcholine receptor M2 (CHRM2) gene with alcohol dependence and major depressive syndrome. Hum Mol Genet 2004;13:1903-1911. https://doi.org/10.1093/hmg/ddh194
  79. Wang JC, Hinrichs AL, Bertelsen S, Stock H, Budde JP, Dick DM, et al. Functional variants in TAS2R38 and TAS2R16 influence alcohol consumption in high-risk families of African-American origin. Alcohol Clin Exp Res 2007;31:209-215. https://doi.org/10.1111/j.1530-0277.2006.00297.x
  80. United Nations (UN). The Universal Declaration of Human Rights. UN web site, . Accessed 20 Feb 2018.
  81. Hasanin M, Dubay DA, McGuire BM, Schiano T, Singal AK. Liver transplantation for alcoholic hepatitis: a survey of liver transplant centers. Liver Transpl 2015;21:1449-1452. https://doi.org/10.1002/lt.24208
  82. Marot A, Dubois M, Trepo E, Moreno C, Deltenre P. Liver transplantation for alcoholic hepatitis: a systematic review with metaanalysis. PLoS One 2018;13:e0190823. https://doi.org/10.1371/journal.pone.0190823
  83. Lee BP, Mehta N, Platt L, Gurakar A, Rice JP, Lucey MR, et al. Outcomes of early liver transplantation for patients with severe alcoholic hepatitis. Gastroenterology 2018;155:422-430.e1. https://doi.org/10.1053/j.gastro.2018.04.009
  84. Lee BP, Terrault NA. Early liver transplantation for severe alcoholic hepatitis: moving from controversy to consensus. Curr Opin Organ Transplant 2018;23:229-236. https://doi.org/10.1097/MOT.0000000000000507
  85. Antonini TM, Guillaud O, Dumortier J, Dharancy S, Saliba F, Mathurin P, et al. Impact of a first study of early transplantation in acute alcoholic hepatitis: results of a nationwide survey in French liver transplantation programs. Liver Transpl 2018;24:841-844. https://doi.org/10.1002/lt.25039

피인용 문헌

  1. Emerging Noninvasive Biomarkers, and Medical Management Strategies for Alcoholic Hepatitis: Present Understanding and Scope vol.9, pp.3, 2018, https://doi.org/10.3390/cells9030524
  2. Outcome of patients with severe alcoholic hepatitis after Model for End-Stage Liver Disease-based allocation system implementation in Korea vol.35, pp.1, 2018, https://doi.org/10.4285/kjt.20.0054